QR kód

The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

Abstract Background Acute myeloid leukemia (AML), a malignancy Often resistant to common chemotherapy regimens (Cytarabine (Ara-c) + Daunorubicin (DNR)), is accompanied by frequent relapses. Many factors are involved in causing chemoresistance. Heme Oxygenase-1 (HO-1) and Hypoxia-Inducible Factor 1-...

Celý popis

Uloženo v:
Hlavní autoři: Mohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Asieh Zarei, Atefeh Khodakarami, Vahid Karpisheh, Ali Masjedi, Badrossadat Rahnama, Mohammad Hojjat-Farsangi, Mortaza Raeisi, Mehdi Yousefi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2024-06-01
Edice:Cancer Cell International
Témata:
Cancer immunotherapy
AML
HO-1
HIF-1α
Cytarabine
Leukemia
On-line přístup:https://doi.org/10.1186/s12935-024-03393-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky